Brief: Polyphor Announces Positive Results From FDA Type B Guidance Meeting

Spexis AG

03/12/2018 06:11

Dec 3 (Reuters) - Polyphor AG  POLN.S :
    * EQS-ADHOC: POLYPHOR ANNOUNCES POSITIVE RESULTS FROM THE
FDA TYPE
B GUIDANCE MEETING ON THE PLANNED PHASE III STUDY FOR
BALIXAFORTIDE
    * EXPECTS TO ENROLL FIRST PATIENT IN Q2 OF 2019

Source text for Eikon:  ID:nEQ2hfgCta 
Further company coverage:  POLN.S 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))